Chengxu Ma

1.0k total citations · 1 hit paper
26 papers, 624 citations indexed

About

Chengxu Ma is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Chengxu Ma has authored 26 papers receiving a total of 624 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Cardiology and Cardiovascular Medicine and 5 papers in Cancer Research. Recurrent topics in Chengxu Ma's work include Effects of Radiation Exposure (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Chengxu Ma is often cited by papers focused on Effects of Radiation Exposure (4 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Chengxu Ma collaborates with scholars based in China, Spain and Australia. Chengxu Ma's co-authors include Songbo Fu, Conghui Guan, Yingdong Li, Xiaoni Ma, Dı́dac Mauricio, Xulei Tang, Xinke Zhao, Na Jiang, Kuan Yang and Jinjin Liu and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Biomedicine & Pharmacotherapy.

In The Last Decade

Chengxu Ma

23 papers receiving 618 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management

2022 234 citations Chengxu Ma, Xiaoni Ma et al. Cardiovascular Diabetology profile →

Peers

Chengxu Ma

EDM

CCM

EPIDE

Yongjun Wang China

Shanhong Lu China

Jiantong Hou China

Shi Tai China

Seung Hee Lee South Korea

Paraskevi Farmaki Greece

Leticia González Chile

Daniel Bulut Germany

Bo Jin China

Hong Zhi China

Yongjun Wang China

Chengxu Ma

168 ×0.6

76 ×0.6

EDM

69 ×0.6

CCM

69 ×0.7

77 ×1.1

EPIDE

Citations per year, relative to Chengxu Ma Chengxu Ma (= 1×) peers Yongjun Wang

Countries citing papers authored by Chengxu Ma

Since Specialization

Citations

This map shows the geographic impact of Chengxu Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengxu Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengxu Ma more than expected).

Fields of papers citing papers by Chengxu Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengxu Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengxu Ma. The network helps show where Chengxu Ma may publish in the future.

Co-authorship network of co-authors of Chengxu Ma

This figure shows the co-authorship network connecting the top 25 collaborators of Chengxu Ma. A scholar is included among the top collaborators of Chengxu Ma based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengxu Ma. Chengxu Ma is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Guan, Conghui, Kuan Yang, Chengxu Ma, et al.. (2025). STING1 targets MYH9 to drive adipogenesis through the AKT/GSK3β/β-catenin pathway. Biochemical and Biophysical Research Communications. 749. 151352–151352.

Ma, Chengxu, Xiaoni Ma, Hongli Li, Dı́dac Mauricio, & Songbo Fu. (2025). Endocrine-disrupting chemicals exposure: cardiometabolic health risk in humans. Cardiovascular Diabetology. 24(1). 381–381.

Liu, Jinjin, Na Jiang, Kuan Yang, et al.. (2023). Codonopsis pilosula polysaccharides promote osteogenic differentiation and inhibit lipogenic differentiation of rat bone marrow stem cells by activating β-catenin. Chemico-Biological Interactions. 385. 110721–110721. 8 indexed citations

Ma, Chengxu, Xiaoni Ma, Conghui Guan, et al.. (2023). The BRAFV600E mutation maintains the aggressiveness of papillary thyroid cancers requiring downregulation of primary cilia. Molecular and Cellular Endocrinology. 581. 112113–112113. 2 indexed citations

Guan, Conghui, Songbo Fu, Donghu Zhen, et al.. (2022). Metabolic (Dysfunction)-Associated Fatty Liver Disease in Chinese Patients with Type 2 Diabetes from a Subcenter of the National Metabolic Management Center. Journal of Diabetes Research. 2022. 1–9. 15 indexed citations

Ma, Chengxu, Xiaoni Ma, Conghui Guan, et al.. (2022). Cardiovascular disease in type 2 diabetes mellitus: progress toward personalized management. Cardiovascular Diabetology. 21(1). 74–74. 234 indexed citations breakdown →

Jiang, Na, et al.. (2022). Thioredoxin-interacting protein: A new therapeutic target in bone metabolism disorders?. Frontiers in Immunology. 13. 955128–955128. 22 indexed citations

Ma, Xiaoni, et al.. (2022). The association of obesity with thyroid carcinoma risk. Cancer Medicine. 11(4). 1136–1144. 6 indexed citations

Fu, Songbo, et al.. (2021). MiR-192-5p inhibits proliferation, migration, and invasion in papillary thyroid carcinoma cells by regulation of SH3RF3. Bioscience Reports. 41(9). 14 indexed citations

10.

Zhao, Xinke, Rongcheng Zhang, Kai Liu, et al.. (2021). Combined use of low T3 syndrome and NT-proBNP as predictors for death in patients with acute decompensated heart failure. BMC Endocrine Disorders. 21(1). 140–140. 6 indexed citations

11.

Chang, Xingyu, et al.. (2021). miRNA, lncRNA and circRNA: Targeted Molecules Full of Therapeutic Prospects in the Development of Diabetic Retinopathy. Frontiers in Endocrinology. 12. 771552–771552. 42 indexed citations

12.

Jiang, Na, Kuan Yang, Jinjin Liu, et al.. (2021). NLRP3 Inflammasome: A New Target for Prevention and Control of Osteoporosis?. Frontiers in Endocrinology. 12. 752546–752546. 90 indexed citations

13.

Ma, Chengxu, Xiaoni Ma, Ying‐Dong Li, & Songbo Fu. (2021). The Role of Primary Cilia in Thyroid Cancer: From Basic Research to Clinical Applications. Frontiers in Endocrinology. 12. 685228–685228. 8 indexed citations

14.

Ma, Chengxu, et al.. (2020). Design of Efficient Convolutional Neural Module Based on An Improved Module. Advances in Science Technology and Engineering Systems Journal. 5(1). 340–345. 1 indexed citations

15.

Ma, Chengxu, Xinke Zhao, Juan Chang, et al.. (2020). Radix Angelica Sinensis and Radix Hedysari Ultrafiltration Extract Protects against X‐Irradiation‐Induced Cardiac Fibrosis in Rats. Evidence-based Complementary and Alternative Medicine. 2020(1). 4675851–4675851. 14 indexed citations

16.

Li, Yaling, et al.. (2020). <p>15-PGDH Expression in Gastric Cancer: A Potential Role in Anti-Tumor Immunity</p>. Cancer Management and Research. Volume 12. 7419–7426. 6 indexed citations

17.

Ma, Chengxu, et al.. (2019). The effects of Radix Angelica Sinensis and Radix Hedysari ultrafiltration extract on X-irradiation-induced myocardial fibrosis in rats. Biomedicine & Pharmacotherapy. 112. 108596–108596. 18 indexed citations

18.

Xiao, Yujie, Yaolong Chen, Xufei Luo, et al.. (2018). Therapeutic effect of angelica and its compound formulas for hypertension and the complications: Evidence mapping. Phytomedicine. 59. 152767–152767. 17 indexed citations

19.

Luo, Haiyan, et al.. (2018). [Effect of Warm Acupuncture on the Levels of Serum Immunoglobulin E, Interleukin-1 β and Tumor Necrosis Factor-α in Rats with Allergic Rhinitis].. PubMed. 43(1). 35–8. 5 indexed citations

20.

Ma, Xiaofei, Chengxu Ma, Wengui Shi, et al.. (2016). Primary cilium is required for the stimulating effect of icaritin on osteogenic differentiation and mineralization of osteoblasts in vitro. Journal of Endocrinological Investigation. 40(4). 357–366. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact